Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatment von Foster, G, Agarwal, K, Cramp, M.E, Moreea, S, Barclay, S, Collier, J, Brown, A.S, Ryder, S.D, Ustianowski, A, Forton, D.M, Fox, R, Gordon, F, Rosenberg, W.M, Mutimer, D.J, Du, J, Gilbert, C.L, Robertson, M, Barr, E, Haber, B

Volltext

Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16 weeks: fin... von Foster, G.R, Agarwal, K, Cramp, M.E, Moreea, S, Barclay, S, Collier, J, Brown, A.S, Ryder, S.D, Ustianowski, A, Forton, D.M, Fox, R, Gordon, F, Rosenberg, W.M, Mutimer, D.J, Du, J, Gilbert, C.L, Robertson, M, Barr, E, Haber, B

Volltext

199 THE EFFECTS OF DISEASE STAGE AND ACUTE-ON-CHRONIC LIVER FAILURE ON THE PROFILE OF PLASMA DIMETHYLARGININES IN CIRRHOSIS von Thomson, S.J, Cowan, M.L, Musa, S, Dalton, R.N, Turner, C, Forton, D.M, Clark, S.J, Rahman, T.M

Volltext

Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C von Thomas, Howard.C., Török, M.E., Forton, D.M., Taylor-Robinson, S.D.

Volltext

736 EVIDENCE OF NEUROINFLAMMATION IN PATIENTS WITH CHRONIC HEPATITIS C: A CEREBRAL POSITRON EMISSION TOMOGRAPHY (PET) STUDY von Grover, V.P, Pavese, N, Koh, S.-B, Wylezinska, M, McGuinness, A, Saxby, B.K, Gerhard, A, Forton, D.M, Thomas, H.C, Brooks, D.J, Taylor-Robinson, S.D

Volltext

604 DIAGNOSIS OF SIGNIFICANT HCV LIVER FIBROSIS WITH SERUM PROTEOMIC PROFILING IN SUBJECTS WITH OPTIMAL LIVER BIOPSIES von Cowan, M.L, Thomson, S.J, Rice, P, Forton, D.M, Rahman, T.M, Krishna, S

Volltext

FRI-215 - Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treat... von Foster, G., Agarwal, K., Cramp, M.E., Moreea, S., Barclay, S., Collier, J., Brown, A.S., Ryder, S.D., Ustianowski, A., Forton, D.M., Fox, R., Gordon, F., Rosenberg, W.M., Mutimer, D.J., Du, J., Gilbert, C.L., Robertson, M., Barr, E., Haber, B.

Volltext

FRI-213 - Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16... von Foster, G.R., Agarwal, K., Cramp, M.E., Moreea, S., Barclay, S., Collier, J., Brown, A.S., Ryder, S.D., Ustianowski, A., Forton, D.M., Fox, R., Gordon, F., Rosenberg, W.M., Mutimer, D.J., Du, J., Gilbert, C.L., Robertson, M., Barr, E., Haber, B.

Volltext

Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels von Forton, D M, Patel, N, Prince, M, Oatridge, A, Hamilton, G, Goldblatt, J, Allsop, J M, Hajnal, J V, Thomas, H C, Bassendine, M, Jones, D E J, Taylor-Robinson, S D

Volltext

180 Diffusion tensor and magnetisation transfer imaging of the brain at 3T in patients with cirrhosis and hepatic encephalopathy von Grover, V.P., Counsell, S.J., Forton, D.M., Bradford, E.J., Saxby, B.K., Thomas, H.C., Hajnal, J.V., Taylor-Robinson, S.D.

Volltext

CORRELATION BETWEEN CEREBRAL PROTON MAGNETIC RESONANCE SPECTROSCOPY INFECTION von Forton, D.M, Hargarden, N, Thomas, H.G, Taylor-Robinson, S.D

Volltext

In vivo quantification of cerebral ‘peripheral benzodiazepine binding site’ in minimal hepatic encephalopathy: a [11C]R-PK11195 positron emission tomography study von Cagnin, A., Taylor-Robinson, S.D., Forton, D.M., Banati, R.B.

Volltext

Proton cerebral magnetic resonance spectroscopy and neuropsychometric abnormalities in patients with chronic hepatitis C infection von Forton, D.M., Hargarden, N., Thomas, H.C., Taylor-Robinson, S.D.

Volltext

INTRACELLULAR pH OF THE BRAIN IN CHRONIC HEPATIC ENCEPHALOPATHY STUDY von Patel, N, Forton, D.M, Hamilton, G, Coutts, G.A, Thomas, H.C, Taylor-Robinson, S.D

Volltext

LO5 : Sofosbuvir + peginterferon/ribavirin for 12 weeks vs sofosbuvir + ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experienced cirrhotic patient... von Foster, G.R, Pianko, S, Cooper, C, Brown, A, Forton, D, Nahass, R.G, George, J, Barnes, E, Brainard, D.M, Massetto, B, Lin, M, McHutchison, J.G, Subramanian, G.M, Agarwal, K

Volltext

P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBA... von Asselah, T, Jensen, D.M, Foster, G.R, Sulkowski, M.S, Ouzan, D, Morano, L, Buynak, R, Agarwal, K, Hassanein, T, Forton, D, Cho, M, Genné, D, Kaita, K, Maieron, A, Preotescu, L, Sarrazin, C, Zehnter, E, Streinu-Cercel, A, Stern, J.O, Datsenko, Y, Drulak, M, Voss, F, Quinson, A.-M, Ferenci, P

Volltext

P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS von Zeuzem, S, Jensen, D.M, Carvalho, A, Diago, M, Feinman, S.V, Kowdley, K.V, Kao, J.-H, Maevskaya, M, Negro, F, Mantry, P, Tanaka, Y, Forton, D, Genné, D, Paik, S.W, Zehnter, E, Kuboki, M, Lee, W.M, Peng, C.-Y, Yatsuhashi, H, Stern, J.O, Datsenko, Y, Drulak, M, Voss, F, Böcher, W, Ferenci, P

Volltext

P723 FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALY... von Asselah, T, Jensen, D.M, Foster, G.R, Sulkowski, M.S, Ouzan, D, Morano, L, Buynak, R, Agarwal, K, Hassanein, T, Forton, D, Negro, F, Genné, D, Kaita, K, Maieron, A, Preotescu, L, Sarrazin, C, Zehnter, E, Romero-Gómez, M, Stern, J.O, Quinson, A.-M, Drulak, M, Garcia, M, Voss, F, Böcher, W, Ferenci, P

Volltext